FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Toto

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Renal Dialysis

Concepts & Ideas

Living Beings

African Americans

Anatomy

Kidneys

Co-author Network

Publications

TOP 3
Peter N Van Buren; Robert D Toto
The pathogenesis and management of hypertension in diabetic kidney disease.
Nishank Jain; Benji Kurian; A John Rush; Ravindra Sarode; Robert D Toto; Madhukar H Trivedi; Thomas Carmody; S Susan Hedayati
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Peter N Van Buren; Catherine Kim; Robert D Toto; Jula K Inrig
The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Toto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Peter N Van Buren; Robert D Toto
The pathogenesis and management of hypertension in diabetic kidney disease.
The Medical clinics of North America 2013;97(1):31-51.
2013: Nishank Jain; Benji Kurian; A John Rush; Ravindra Sarode; Robert D Toto; Madhukar H Trivedi; Thomas Carmody; S Susan Hedayati
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Contemporary clinical trials 2013;34(1):136-44.
2012: Peter N Van Buren; Catherine Kim; Robert D Toto; Jula K Inrig
The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up.
The International journal of artificial organs 2012;35(12):1031-8.
2012: Jula K Inrig; Catherine Kim; Thomas J Povsic; Peter Van Buren; Wanpen Vongpatanasin; Robert D Toto
Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(8):1300-9.
2012: Robert D Toto
RAS blockade, hyperkalemia and AKI--look and you will find.
Nature reviews. Nephrology 2012;8(5):257-8.
2012: Liang Li; Michael S Lipkowitz; Robert D Toto; Xuelei Wang; Jackson T Wright; Lawrence J Appel; Brad C Astor; Bo Hu; Julia Lewis; Tom H Greene
Longitudinal progression trajectory of GFR among patients with CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;59(4):504-12.
2011: Jula K Inrig; Catherine Kim; Thomas J Povsic; Peter Van Buren; Wanpen Vongpatanasin; Robert D Toto
Intradialytic hypertension and its association with endothelial cell dysfunction.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(8):2016-24.
2011: Peter N Van Buren; Catherine Kim; Robert D Toto; Jula K Inrig
Intradialytic hypertension and the association with interdialytic ambulatory blood pressure.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(7):1684-91.
2011: Louis Kuritzky; Robert D Toto; Peter Van Buren
Identification and management of albuminuria in the primary care setting.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(6):438-49.
2011: Jula K Inrig; Robert D Toto
Differential outcomes between dialysis modalities: purely a reflection of selection bias?
Journal of the American Society of Nephrology : JASN 2011;22(6):989-90.
2011: Esa M Davis; Tom Greene; Michael Lipkowitz; Velvie A Pogue; Mahboob Rahman; Robert D Toto; Xuelei Wang; Jackson T Wright; Lawrence J Appel; Brad C Astor
Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
Hypertension 2011;57(6):1061-8.
2010: Peter Noel Van Buren; Beverley Adams-Huet; Robert D Toto
Effective antihypertensive strategies for high-risk patients with diabetic nephropathy.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2010;58(8):950-6.
2010: Robert D Toto; Tom Greene; Lee A Hebert; Leena Hiremath; Janice P Lea; Julia B Lewis; Velvie Pogue; Mohammed Sika; Xuelei Wang
Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;56(5):896-906.
2010: Lawrence J Appel; Jackson T Wright; Tom Greene; Lawrence Y Agodoa; Brad C Astor; George L Bakris; William H Cleveland; Jeanne Charleston; Gabriel Contreras; Marquetta Faulkner; Francis B Gabbai; Jennifer J Gassman; Lee A Hebert; Kenneth A Jamerson; Joel D Kopple; John W Kusek; James P Lash; Janice P Lea; Julia B Lewis; Michael S Lipkowitz; Shaul G Massry; Edgar R Miller; Keith Norris; Robert A Phillips; Velvie A Pogue; Otelio S Randall; Stephen G Rostand; Miroslaw J Smogorzewski; Robert D Toto; Xuelei Wang
Intensive blood-pressure control in hypertensive chronic kidney disease.
The New England journal of medicine 2010;363(10):918-29.
2010: Robert D Toto
Aldosterone blockade in chronic kidney disease: can it improve outcome?
Current opinion in nephrology and hypertension 2010;19(5):444-9.
2010: S Susan Hedayati; Abu T Minhajuddin; Masoud Afshar; Robert D Toto; Madhukar H Trivedi; A John Rush
Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death.
JAMA : the journal of the American Medical Association 2010;303(19):1946-53.
2010: Robert D Toto
Screening and evaluation of study subjects in patient-oriented research.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2010;58(4):608-11.
2010: Robert D Toto
Debate: PRO Position. People with chronic kidney disease should have a blood pressure lower than 130/80 mm Hg.
American journal of nephrology 2010;32(4):370-3; discussion 379-80.
2009: Uzma F Mehdi; Beverley Adams-Huet; Philip Raskin; Gloria L Vega; Robert D Toto
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.
Journal of the American Society of Nephrology : JASN 2009;20(12):2641-50.
2009: Jula K Inrig; Robert D Toto
Is choice of antihypertensive agent important in improving cardiovascular outcomes in high-risk hypertensive patients?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(6):1000-4.
2009: Jula K Inrig; Uptal D Patel; Robert D Toto; Donal N Reddan; Jonathan Himmelfarb; Robert M Lindsay; John Stivelman; James Winchester; Lynda A Szczech
Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes.
Kidney international 2009;76(10):1098-107.
2009: Andrew S Bomback; Robert D Toto
Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
American journal of hypertension 2009;22(10):1032-40.
2009: S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; john rush
Validation of depression screening scales in patients with CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(3):433-9.
2009: S Susan Hedayati; Abu T Minhajuddin; Robert D Toto; David W Morris; john rush
Prevalence of major depressive episode in CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(3):424-32.
2008: THAI NGUYEN; Robert D Toto
Slowing chronic kidney disease progression: results of prospective clinical trials in adults.
Pediatric nephrology (Berlin, Germany) 2008;23(9):1409-22.
2008: Robert D Toto
How to launch a successful career in clinical research: tips on making the most of available resources.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2008;56(6):843-6.
2008: A Mohanram; Z Zhang; Shahnaz Shahinfar; Paulette A Lyle; Robert D Toto
The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes.
Kidney international 2008;73(5):630-6.
2008: U Baber; James A de Lemos; Amit Khera; Darren K McGuire; Torbjørn Omland; Robert D Toto; S Susan Hedayati
Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort.
Kidney international 2008;73(5):615-21.
2007: Robert D Toto
Reducing cardiovascular events in high-risk patients: the challenge of managing hypertension in patients with diabetic renal disease.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(11 Suppl 4):16-25.
2007: Srinivasan Beddhu; Alfred K Cheung; Brett Larive; Tom Greene; George A Kaysen; Andrew S Levey; Michael Rocco; Mark J Sarnak; Robert D Toto; Garabed Eknoyan
Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2007;17(6):372-80.
2007: Mohammed Sika; Julia Lewis; Janice Douglas; Thomas Erlinger; Donna Dowie; Michael Lipkowitz; James P Lash; Denise Cornish-Zirker; Gail Peterson; Robert D Toto; John W Kusek; Lawrence J Appel; Cynthia Kendrick; Jennifer Gassman
Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(1):78-89, 89.e1.
2007: Usman Baber; Robert D Toto; James A de Lemos
Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure.
American heart journal 2007;153(4):471-7.
2007: Richard E Gilbert; Sandra A Kim; Katherine R Tuttle; George L Bakris; Robert D Toto; Janet B McGill; Douglas J Haney; Darren J Kelly; Pamela W Anderson
Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 diabetes.
Diabetes care 2007;30(4):995-6.
2007: Betsy A George; Xin J Zhou; Robert D Toto
Nephrotic syndrome after bevacizumab: case report and literature review.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(2):e23-9.
2007: THAI NGUYEN; Miguel Vazquez; Robert D Toto
Living kidney donation and hypertension risk.
Lancet 2007;369(9556):87-8.
2007: Justin Teiwes; Robert D Toto
Epithelial sodium channel inhibition in cardiovascular disease. A potential role for amiloride.
American journal of hypertension 2007;20(1):109-17.
2006: Keith C Norris; Jacque Bourgoigne; Jennifer Gassman; Lee Hebert; John Middleton; Robert A Phillips; Otelio S Randall; Stephen G Rostand; Susan Sherer; Robert D Toto; Jackson T Wright; Xuelei Wang; Tom Greene; Lawrence J Appel; Julia Lewis
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;48(5):739-51.
2006: Xuelei Wang; Julia Lewis; Lawrence J Appel; DeAnna E. Cheek; Gabriel Contreras; Marquetta Faulkner; Harold Feldman; Jennifer Gassman; Janice P Lea; Joel D Kopple; Mohammed Sika; Robert D Toto; Tom Greene
Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease.
Journal of the American Society of Nephrology : JASN 2006;17(10):2900-9.
2006: Robert D Toto
Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
Current hypertension reports 2006;8(5):409-12.
2006: William F Keane; Zhongxin Zhang; Paulette A Lyle; Mark E Cooper; Dick De Zeeuw; Jean-Pierre Grunfeld; James P Lash; Janet B McGill; William E Mitch; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Robert D Toto; Barry M Brenner
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.
Clinical journal of the American Society of Nephrology : CJASN 2006;1(4):761-7.
2006: Yue-Harn Ng; Klemens B Meyer; John W Kusek; Guofen Yan; Michael V Rocco; Paul L Kimmel; Robert L Benz; Srinivasan Beddhu; Johanna T Dwyer; Robert D Toto; Garabed Eknoyan; Mark L Unruh
Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(4):614-24.
2005: Robert D Toto
Treatment of hypertension in chronic kidney disease.
Seminars in nephrology 2005;25(6):435-9.
2005: Robert D Toto
Heart disease in diabetic patients.
Seminars in nephrology 2005;25(6):372-8.
2005: Katherine R Tuttle; George L Bakris; Robert D Toto; Janet B McGill; Kuolung Hu; Pamela W Anderson
The effect of ruboxistaurin on nephropathy in type 2 diabetes.
Diabetes care 2005;28(11):2686-90.
2005: Tom Greene; John T Daugirdas; Thomas A Depner; Michael Allon; Gerald Beck; Cameron Chumlea; James A Delmez; Frank Gotch; John W Kusek; Nathan Levin; William Owen; Gerald Schulman; robert star; Robert D Toto; Garabed Eknoyan
Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias".
Journal of the American Society of Nephrology : JASN 2005;16(11):3371-80.
2005: Robert D Toto
Proteinuria reduction: mandatory consideration or option when selecting an antihypertensive agent?
Current hypertension reports 2005;7(5):374-8.
2005: Michael Wiederkehr; Robert D Toto; Andrew Z Fenves; C Venkata S Ram
Hypertension and the kidney.
Seminars in nephrology 2005;25(4):236-45.
2005: Gabriel Contreras; Tom Greene; Lawrence Y Agodoa; DeAnna E. Cheek; George Junco; Donna Dowie; James P Lash; Michael Lipkowitz; Edgar R Miller; Akinlolu O Ojo; Mohammed Sika; Beth Wilkening; Robert D Toto
Blood pressure control, drug therapy, and kidney disease.
Hypertension 2005;46(1):44-50.
2005: Robert D Toto
Management of hypertensive chronic kidney disease: role of calcium channel blockers.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(4 Suppl 1):15-20.
2005: T-Christian H Mix; Robert M Brenner; Mark E Cooper; Dick de Zeeuw; Peter Ivanovich; Andrew S Levey; Janet B McGill; john mcmurray; Patrick S Parfrey; Hans-Henrik Parving; Brian J G Pereira; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Catherine Stehman-Breen; Robert D Toto; Marc A Pfeffer
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
American heart journal 2005;149(3):408-13.
2004: Julia Lewis; Tom Greene; Lawrence J Appel; Gabriel Contreras; Janice Douglas; James P Lash; Robert D Toto; Frederick Van Lente; Xuelei Wang; Jackson T Wright
A comparison of iothalamate-GFR and serum creatinine-based outcomes: acceleration in the rate of GFR decline in the African American Study of Kidney Disease and Hypertension.
Journal of the American Society of Nephrology : JASN 2004;15(12):3175-83.
2004: Robert D Toto
Lessons learned from recent clinical trials in hypertensive diabetics: what's good for the kidney is good for the heart and brain.
American journal of hypertension 2004;17(11 Pt 2):7S-10S; quiz A2-4.
2004: Robert D Toto
Microalbuminuria: definition, detection, and clinical significance.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(11 Suppl 3):2-7.
2004: Robert D Toto
Proteinuria and hypertensive nephrosclerosis in African Americans.
Kidney international. Supplement 2004;(92):S102-4.
2004: Anupama Mohanram; Zhongxin Zhang; Shahnaz Shahinfar; William F Keane; Barry M Brenner; Robert D Toto
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.
Kidney international 2004;66(3):1131-8.
2004: Robert D Toto; Steven Rinner; C Venkata S Ram
ACE inhibitors and target organ protection. An expanded role for these antihypertensive agents?
Postgraduate medicine 2004;116(2):11-6, 19-22, 48.
2004: Robert D Toto; Vincent Pichette; Jesus Navarro; Robert Brenner; Wendi Carroll; Wei Liu; Simon Roger
Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration.
American journal of nephrology 2004;24(4):453-60.
2004: Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen M Kaufman; Julia Lewis; Michael Rocco; Robert D Toto; David Windus; Daniel Ornt; Andrew S Levey
Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.
Kidney international 2004;65(6):2380-9.
2004: Thomas A Depner; John T Daugirdas; Tom Greene; Michael Allon; Gerald Beck; Cameron Chumlea; James A Delmez; Frank Gotch; John W Kusek; Nathan Levin; Edwin Macon; Edgar Milford; William Owen; robert star; Robert D Toto; Garabed Eknoyan
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study.
Kidney international 2004;65(4):1386-94.
2003: George A Kaysen; Tom Greene; John T Daugirdas; Paul L Kimmel; Gerald Schulman; Robert D Toto; Nathan W Levin; Guofen Yan
Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(6):1200-11.
2003: Robert D Toto
Anemia of chronic disease: past, present, and future.
Kidney international. Supplement 2003;(87):S20-3.
2003: Garabed Eknoyan; Thomas H Hostetter; George L Bakris; Lee Hebert; Andrew S Levey; Hans-Henrik Parving; Michael W Steffes; Robert D Toto
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(4):617-22.
2003: Tazeen H Jafar; Christopher Schmid; Paul C Stark; Robert D Toto; Giuseppe Remuzzi; Piero Ruggenenti; Carmelita Marcantoni; Gavin Becker; Shahnaz Shahinfar; Paul E de Jong; Dick de Zeeuw; Anne-Lise Kamper; Svend Strangaard; Andrew S Levey
The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(10):2047-53.
2003: Glenn M Chertow; Paolo Raggi; James T McCarthy; Gerald Schulman; Jeffrey Silberzweig; Amy Kuhlik; William G Goodman; Amy Boulay; Steven K Burke; Robert D Toto
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.
American journal of nephrology 2003;23(5):307-14.
2003: Tazeen H Jafar; Paul C Stark; Christopher Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert D Toto; Andrew S Levey
Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.
Annals of internal medicine 2003;139(4):244-52.
2003: Anupama Mohanram; Robert D Toto
Outcome studies in diabetic nephropathy.
Seminars in nephrology 2003;23(3):255-71.
2003: William F Keane; Barry M Brenner; Dick De Zeeuw; Jean-Pierre Grunfeld; Janet McGill; William E Mitch; Artur B Ribeiro; Shahnaz Shahinfar; Roger L Simpson; Steven M Snapinn; Robert D Toto
The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study.
Kidney international 2003;63(4):1499-507.
2002: Garabed Eknoyan; Gerald J Beck; Alfred K Cheung; John T Daugirdas; Tom Greene; John W Kusek; Michael Allon; James Bailey; James A Delmez; Thomas A Depner; Johanna T Dwyer; Andrew S Levey; Nathan W Levin; Edgar Milford; Daniel Ornt; Michael V Rocco; Gerald Schulman; Steve J Schwab; Brendan P Teehan; Robert D Toto
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
The New England journal of medicine 2002;347(25):2010-9.
2002: Robert D Toto
Appropriate drug therapy for improving outcomes in diabetic nephropathy.
Current diabetes reports 2002;2(6):545-52.
2002: Jackson T Wright; George L Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna E. Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth A Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
JAMA : the journal of the American Medical Association 2002;288(19):2421-31.
2002: Meryem Tuncel; Robert A Augustyniak; Weiguo Zhang; Robert D Toto; Ronald G Victor
Sympathetic nervous system function in renal hypertension.
Current hypertension reports 2002;4(3):229-36.
2002: Robert A Augustyniak; Meryem Tuncel; Weiguo Zhang; Robert D Toto; Ronald G Victor
Sympathetic overactivity as a cause of hypertension in chronic renal failure.
Journal of hypertension 2002;20(1):3-9.
2001: Tazeen H Jafar; Christopher Schmid; Marcia Landa; I Giatras; Robert D Toto; Giuseppe Remuzzi; Giuseppe Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; Shahnaz Shahinfar; Paul E de Jong; Dick de Zeeuw; J Lau; Andrew S Levey
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.
Annals of internal medicine 2001;135(2):73-87.
2000: W J Elliott; R Maddy; Robert D Toto; G Bakris
Hypertension in patients with diabetes. Overcoming barriers to effective control.
Postgraduate medicine 2000;107(3):29-32, 35-6, 38.
2000: Robert D Toto; Scott M Grundy; Gloria Lena Vega
Pravastatin treatment of very low density, intermediate density and low density lipoproteins in hypercholesterolemia and combined hyperlipidemia secondary to the nephrotic syndrome.
American journal of nephrology 2000;20(1):12-7.
1998: Josef Coresh; Robert D Toto; KA Kirk; Paul K Whelton; Shaul G Massry; C Jones; Lawrence Agodoa; Frederick Van Lente
Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(1):32-42.
1998: Robert D Toto; P Shultz; Leopoldo Raij; H Mitchell; Wayne Shaw; Denise Ramjit; J Toh; Shahnaz Shahinfar
Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group.
Hypertension 1998;31(2):684-91.
1997: H C Mitchell; R D Smith; R E Cutler; D Sica; J Videen; S Thompsen-Bell; K Jones; C Bradley-Guidry; Robert D Toto
Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(6):897-906.
1997: Robert D Toto; KA Kirk; Josef Coresh; C Jones; Lawrence J Appel; J Wright; V Campese; B Olutade; Lawrence Agodoa
Evaluation of serum creatinine for estimating glomerular filtration rate in African Americans with hypertensive nephrosclerosis: results from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Journal of the American Society of Nephrology : JASN 1997;8(2):279-87.
1996: Robert D Toto; Beverley Adams-Huet; A Z Fenves; H C Mitchell; W Mulcahy; R D Smith
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(6):832-40.
1996: J T Wright; John W Kusek; Robert D Toto; J Y Lee; L Y Agodoa; KA Kirk; O S Randall; R Glassock
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.
Controlled clinical trials 1996;17(4 Suppl):3S-16S.
1996: Robert D Toto
Treatment of dyslipidemia in chronic renal failure.
Blood purification 1996;14(1):75-82.
1995: Robert D Toto
Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and para-aminohippuric acid clearance.
Current opinion in nephrology and hypertension 1995;4(6):505-9; discussion 503-4.
1995: Robert D Toto; H C Mitchell; R D Smith; H C Lee; D McIntire; W A Pettinger
"Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.
Kidney international 1995;48(3):851-9.
1995: M M Bankhead; Robert D Toto; robert star
Accuracy of urea removal estimated by kinetic models.
Kidney international 1995;48(3):785-93.
1995: Gloria Lena Vega; Robert D Toto; Scott M Grundy
Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
Kidney international 1995;47(2):579-86.
1994: N Ahsan; Biff F Palmer; D Wheeler; R G Greenlee; Robert D Toto
Intravenous immunoglobulin-induced osmotic nephrosis.
Archives of internal medicine 1994;154(17):1985-7.
1994: Robert D Toto; H C Mitchell; W A Pettinger
Treatment of hypertension in nondiabetic renal disease.
Current opinion in nephrology and hypertension 1994;3(3):279-85.
1994: Robert D Toto
Renal insufficiency due to angiotensin-converting enzyme inhibitors.
Mineral and electrolyte metabolism 1994;20(4):193-200.
1993: Robert D Toto; Gloria Lena Vega; Scott M Grundy
Mechanisms and treatment of dyslipidemia of renal diseases.
Current opinion in nephrology and hypertension 1993;2(5):784-90.
1993: R Agarwal; Robert D Toto
Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;22(2):296-9.
1993: K Arrambide; Robert D Toto
Tumor lysis syndrome.
Seminars in nephrology 1993;13(3):273-80.
1992: R L Converse; T N Jacobsen; Robert D Toto; C M Jost; F Cosentino; F Fouad-Tarazi; Ronald G Victor
Sympathetic overactivity in patients with chronic renal failure.
The New England journal of medicine 1992;327(27):1912-8.
1992: R L Converse; T N Jacobsen; C M Jost; Robert D Toto; Paul A Grayburn; T M Obregon; F Fouad-Tarazi; Ronald G Victor
Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.
The Journal of clinical investigation 1992;90(5):1657-65.
1991: Robert D Toto; H C Mitchell; H C Lee; C Milam; W A Pettinger
Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis.
Annals of internal medicine 1991;115(7):513-9.
1991: Biff F Palmer; Robert D Toto
Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;18(1):116-21.
1991: Robert D Toto
The role of prostaglandins in NSAID induced renal dysfunction.
The Journal of rheumatology. Supplement 1991;28():22-5.
1991: Robert D Toto
Role of prostaglandins in NSAID-induced renal dysfunction.
Advances in prostaglandin, thromboxane, and leukotriene research 1991;21B():967-74.
1990: Robert D Toto
Acute tubulointerstitial nephritis.
The American journal of the medical sciences 1990;299(6):392-410.
1990: I J Dawidson; L Coorpender; D Fisher; H Helderman; A Hull; B Palmer; P Peters; Arthur I Sagalowsky; Z F Sandor; Robert D Toto
Impact of race on renal transplant outcome.
Transplantation 1990;49(1):63-7.
1989: B G Firth; R Perna; J F Bellomo; Robert D Toto
Cardiorenal effects of atrial natriuretic factor administration in congestive heart failure: natriuresis and diuresis without hemodynamic alterations.
The American journal of the medical sciences 1989;297(4):203-8.
1988: J H Helderman; J Hernandez; A Sagalowsky; I Dawidson; J Glennie; D Womble; Robert D Toto; K Brinker; A R Hull
Confirmation of the utility of fine needle aspiration biopsy of the renal allograft.
Kidney international 1988;34(3):376-81.
1988: J A Hernandez; J Glennie; Robert D Toto; Arthur I Sagalowsky; I Dawidson; J Harold Helderman
A novel use of fine-needle aspiration biopsy: documentation of acute pyelonephritis of the transplanted kidney.
Transplantation proceedings 1988;20(4):632-4.
1988: Arthur I Sagalowsky; M E Reisman; I Dawidson; Robert D Toto; P C Peters; J Harold Helderman
Late cyclosporine conversion carries risk of irreversible rejection.
Transplantation proceedings 1988;20(3 Suppl 3):157-60.
1987: J Harold Helderman; J Hernandez; J Glennie; A Sagalowksy; Robert D Toto; J P Kokko
Confirmation of the utility of the fine needle aspiration biopsy of the transplanted kidney.
Transplantation proceedings 1987;19(1 Pt 2):1653-4.
1987: Patricia A Preisig; Robert D Toto; Robert J Alpern
Carbonic anhydrase inhibitors.
Renal physiology 1987;10(3-4):136-59.
1986: Robert D Toto; S A Anderson; D Brown-Cartwright; J P Kokko; D C Brater
Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency.
Kidney international 1986;30(5):760-8.
1986: D C Brater; S A Anderson; D Brown-Cartwright; Robert D Toto
Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1986;8(5):351-5.
1985: D C Brater; S A Anderson; D Brown-Cartwright; Robert D Toto; A Chen; G B Jacob
Effect of etodolac in patients with moderate renal impairment compared with normal subjects.
Clinical pharmacology and therapeutics 1985;38(6):674-9.